Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Gaudy-Marquestre

Showing results (1-10 of 1) with videos related to

Pageof 1
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 6, 2022
Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trialMarie Véron, Sylvie Chevret, Jean-Jacques Grob, et al.
Pageof 1

Showing results (1-10 of 1) with videos related to

Sort By:
Pageof 1
European Journal of Cancer (Oxford, England : 1990)|November 6, 2022
Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trialMarie Véron, Sylvie Chevret, Jean-Jacques Grob, et al.
Pageof 1